Clostridium difficile infection: An update for infection control practitioners

Healthcare Infection

Volumn 14, Issue 3, 2009, Pages 115-118

  Van Gessel, Helen ^a   Riley, Thomas ^b,c   McGregor, Alistair ^d  

^a DEPARTMENT OF HEALTH   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; ENVIRONMENTAL SANITATION; HUMAN; HYGIENE; INCIDENCE; INFECTION CONTROL; INFECTION CONTROL PRACTITIONER; INFECTION PREVENTION; INFECTION RATE; PATIENT IDENTIFICATION; PATIENT MONITORING; RELAPSE; REVIEW; RISK FACTOR;

EID: 77953463291     PISSN: 18355617     EISSN: None     Source Type: Journal    
DOI: 10.1071/HI09105     Document Type: Article

References (22)

1. Sunenshine R, McDonald L. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006; 73: 187-197
2. Bartlett J. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758-764 (Pubitemid 351650356)
3. McGregor A, Riley T, Van Gessel H. Clostridium difficile-associated disease. In: Cruickshank M, Ferguson J, editors. Reducing harm to patients from health care associated infection: the role of surveillance. Canberra: Australian Commission on Safety and Quality in Health Care; 2008. pp. 171-187
4. Dubberke E, Gerding D, Classen D, Arias K, Podgorny K, Anderson D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: S81-92. doi:10.1086/591065
5. Department of Health. Clostridium difficile infection: how to deal with the problem. London: Department of Health; 2008. Available online at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1232006607827 [accessed February 2009].
6. Miller M. Clinical management of Clostridium difficile-associated disease. Clin Infect Dis 2007; 45: S122-8. doi:10.1086/519257 (Pubitemid 47328626)
7. Loo V, Poirier L, Miller M, Oughton M, Libman M, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-2449 doi:10.1056/NEJMoa051639 (Pubitemid 41770165)
8. Price M, Dao-Tan R, Garey K, Graham G, Gentry L, Dhungana L, et al. Epidemiology and incidence of Clostridium difficile-associated disease following discharge from an acute care hospital. J Hosp Infect 2007; 28: 926-931
9. Chang H, Krezolek D, Johnson S, Parada J, Evans C, Gerding D. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007; 28: 926-931 doi:10.1086/519178 (Pubitemid 47218271)
10. Kuijper E, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12: 2-18. doi:10.1111/j.1469-0691.2006.01580.x (Pubitemid 44362038)
11. McMaster-Baxter NL, Musher DM. Clostridium difficile: recent epidemiologic finding and advances in therapy. Pharmacotherapy 2007; 27: 1029-1039 doi:10.1592/phco.27.7.1029
12. McDonald L, Owings M, Jernigan D. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-415
13. Pepin J, Valiquette L, Alary M, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhoea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004; 171: 466-472 doi:10.1503/cmaj.1041104
14. McDonald L. Confronting Clostridium difficile in inpatient health care facilities. Clin Infect Dis 2007; 45: 1274-1276 doi:10.1086/522655
15. McDonald L, Coignard B, Dubberke E, Song X, Horan T, Kutty P. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-145 doi:10.1086/511798 (Pubitemid 46374153)
16. National Healthcare Safety Network. Multidrug-resistant organism (MDRO) and Clostridium difficile-associated disease (CDAD) module. Atlanta, GA: Centers for Disease Control and Prevention; 2009. Available online at: http://www.cdc.gov/nhsn/mdro-cdad.html [verified April 2009].
17. Riley T. Clostridium difficile as an indicator organism for infection control and surveillance purposes. Aust Infect Control 2002; 7: v-vii.
18. Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I. European Study Group on Clostridium difficile (ESGCD). Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007; 13: 1048-1057 doi:10.1111/j.1469-0691.2007.01824.x
19. Goorhuis A, Debast S, van Leengoed L, Harmanus C, Notermans D, Bergwerff A, et al. Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs? J Clin Microbiol 2008; 46: 1157-1158 doi:10.1128/JCM.01536-07
20. Kim H, Riley T, Kim M, Kim C, Yong D, Lee K, et al. Increasing prevalence of toxin A-negative, toxin-B positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J Clin Microbiol 2008; 46: 1116-1117 doi:10.1128/JCM.01188-07
21. Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30: 346-353 doi:10.1086/596605
22. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008; 62: 601-607 doi:10.1093/jac/dkn199